
|Articles|August 1, 1998
The American Journal of Managed Care
- August 1998
- Volume 4
- Issue 8
Treatment Options for Prostate Cancer: Part 2 -- Early and Late Stage and Hormone Refractory Disease
Author(s)LTC Judd W. Moul, MD, MC, USA
Advertisement
Articles in this issue
over 27 years ago
Identification and Assessment of High-Risk Seniorsover 27 years ago
Outpatient Antidepressant Utilization in a Dutch Sick Fundover 27 years ago
Inborn Errors of Metabolism: Medical and Administrative "Orphans"over 27 years ago
Generic Drug Product Equivalence: Current StatusNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Bronchiectasis Hospitalizations Deadlier, Costlier Than Those for COPD, Asthma
2
FDA Approves Sevabertinib for Nonsquamous NSCLC
3
Family Caregivers Report Weak Coordination With Medical Professionals
4
FDA Approves Selumetinib for Adults With Neurofibromatosis Type 1
5















































